1. Tocilizumab monotherapy after ultra-short glucocorticoid administration in giant cell arteritis: a single-arm, open-label, proof-of-concept study. (September 2021) Authors: Christ, Lisa; Seitz, Luca; Scholz, Godehard; Sarbu, Adela-Cristina; Amsler, Jennifer; Bütikofer, Lukas; Tappeiner, Christoph; Kollert, Florian; Reichenbach, Stephan; Villiger, Peter M Journal: Lancet Issue: Volume 3:Number 9(2021) Page Start: e619 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Divergent regulatory T cell responses to high-dose methylprednisolone and tocilizumab in giant cell arteritis. Issue 133 (December 2022) Authors: Scholz, Godehard A.; Fux, Michaela; Christ, Lisa; Iype, Joseena; Banz, Yara; Villiger, Peter M. Journal: Journal of autoimmunity Issue: Issue 133(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Quantitative ultrasound to monitor the vascular response to tocilizumab in giant cell arteritis. (2nd October 2021) Authors: Seitz, Luca; Christ, Lisa; Lötscher, Fabian; Scholz, Godehard; Sarbu, Adela-Cristina; Bütikofer, Lukas; Kollert, Florian; Schmidt, Wolfgang A; Reichenbach, Stephan; Villiger, Peter M Journal: Rheumatology Issue: Volume 60:Number 11(2021) Page Start: 5052 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. No blood for dark-blood: false-negative MRI in a patient with giant cell arteritis and occluded left temporal artery. (14th October 2020) Authors: Seitz, Luca; Wagner, Franca; Christ, Lisa; Banz, Yara; Villiger, Peter; Kollert, Florian Journal: Rheumatology Issue: Volume 60:Number 4(2021) Page Start: 2025 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗